Jefferies Downgrades Option Care Health (OPCH) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
Option Care Health (OPCH) PT Lowered to $34 at Truist Securities
October 31, 2024 6:10 AM EDTTruist Securities analyst David MacDonald lowered the price target on Option Care Health (NASDAQ: OPCH) to $34.00 (from $41.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy on OPCH post 3Q where solid results/'24 guide were overshadowed by cautious commentary surrounding... More
Option Care Health (OPCH) PT Lowered to $30 at Deutsche Bank
October 31, 2024 5:57 AM EDTDeutsche Bank analyst Pito Chickering lowered the price target on Option Care Health (NASDAQ: OPCH) to $30.00 (from $36.00) while maintaining a Buy rating.
The analyst comments "OPCH reported 3Q revenue 5% ahead of consensus with gross profit and EBITDA in line with estimates as gross margin and EBITDA margin came in 100 and 40 bps light respectively. Going into the call we believe investors were assessing the more or less in-line 3Q results alongside implied 4Q results for revenue 2.4% ahead of Street with EBITDA 4% below, and how much of that could be from transitory factors like the... More
